Partin A - Search Results

1

High prevalence of screen detected prostate cancer in West Africans: implications for racial disparity of prostate cancer.

Hsing AW, Yeboah E, Biritwum R, Tettey Y, De Marzo AM, Adjei A, Netto GJ, Yu K, Li Y, Chokkalingam AP, Chu LW, Chia D, Partin A, Thompson IM, Quraishi SM, Niwa S, Tarone R, Hoover RN. Hsing AW, et al. Among authors: partin a. J Urol. 2014 Sep;192(3):730-5. doi: 10.1016/j.juro.2014.04.017. Epub 2014 Apr 18. J Urol. 2014. PMID: 24747091 Free PMC article.

2

Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.

Epstein JI, Pizov G, Steinberg GD, Carter HB, Pitcock R, Armas OA, Partin A, Walsh PC. Epstein JI, et al. Among authors: partin a. J Urol. 1992 Jul;148(1):87-91. doi: 10.1016/s0022-5347(17)36518-7. J Urol. 1992. PMID: 1613888 Free article. Review.

3

Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia.

Partin AW, Carter HB, Chan DW, Epstein JI, Oesterling JE, Rock RC, Weber JP, Walsh PC. Partin AW, et al. J Urol. 1990 Apr;143(4):747-52. doi: 10.1016/s0022-5347(17)40079-6. J Urol. 1990. PMID: 1690309 Free article.

4

The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. Carter HB, et al. Among authors: partin aw. J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1. doi: 10.1016/s0022-5347(17)39683-0. J Urol. 1990. PMID: 1700143

5

Influence of age and endocrine factors on the volume of benign prostatic hyperplasia.

Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Partin AW, et al. J Urol. 1991 Feb;145(2):405-9. doi: 10.1016/s0022-5347(17)38353-2. J Urol. 1991. PMID: 1703242 Free article.

6

The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia.

Weber JP, Oesterling JE, Peters CA, Partin AW, Chan DW, Walsh PC. Weber JP, et al. Among authors: partin aw. J Urol. 1989 Apr;141(4):987-92. doi: 10.1016/s0022-5347(17)41083-4. J Urol. 1989. PMID: 2467015

7

A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis.

Partin AW, Walsh AC, Pitcock RV, Mohler JL, Epstein JI, Coffey DS. Partin AW, et al. J Urol. 1989 Nov;142(5):1254-8. doi: 10.1016/s0022-5347(17)39049-3. J Urol. 1989. PMID: 2810502

8

Prediction of metastatic potential in an animal model of prostate cancer: flow cytometric quantification of cell surface charge.

Carter HB, Partin AW, Coffey DS. Carter HB, et al. Among authors: partin aw. J Urol. 1989 Nov;142(5):1338-41. doi: 10.1016/s0022-5347(17)39093-6. J Urol. 1989. PMID: 2810530

9

Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer.

Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Partin AW, et al. J Urol. 1989 Feb;141(2):341-5. doi: 10.1016/s0022-5347(17)40761-0. J Urol. 1989. PMID: 2913356

10

Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections.

Mohler JL, Partin AW, Epstein JI, Lohr WD, Coffey DS. Mohler JL, et al. Among authors: partin aw. J Urol. 1988 May;139(5):1085-90. doi: 10.1016/s0022-5347(17)42792-3. J Urol. 1988. PMID: 3283380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

650 results

Search Page

Filters